Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome

被引:11
作者
Espinosa, E. [1 ]
Pena-Jimenez, A. [1 ]
Ormsby, C. E. [1 ]
Vega-Barrientos, R. [1 ]
Reyes-Teran, G. [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosip Villegas, Ctr Infect Dis Res CIENI, Mexico City 14080, DF, Mexico
关键词
antiretroviral; highly active antiretroviral therapy; immune reconstitution inflammatory syndrome (IRIS); immune recovery; RISK-FACTORS; ANTIRETROVIRAL THERAPY; DISEASE;
D O I
10.1111/j.1468-1293.2009.00700.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives The aim of the study was to determine whether immune reconstitution inflammatory syndrome (IRIS) associated with herpes zoster occurs on a different time frame from other instances of IRIS. Methods Statistical analysis of onset times of herpes zoster-associated IRIS and other cases of IRIS was carried out in a retrospective cohort starting antiretroviral therapy at advanced stages of HIV infection. Results Herpes zoster-associated IRIS was significantly more frequent after the first 3 months of successful highly active antiretroviral therapy (HAART), than other instances of IRIS (IRIS associated with tuberculosis, Mycobacterium avium complex, Kaposi's sarcoma, etc.) which mainly occurred during the first 3 months of treatment. Conclusions The characteristic onset time pattern of herpes zoster-associated IRIS, coincident with the second phase of immune recovery under HAART, suggests that the immune recovery events underlying herpes zoster-associated IRIS are different from those underlying other types of IRIS. Our findings may be useful in improving the follow-up of individuals who start HAART at an advanced stage of HIV infection.
引用
收藏
页码:454 / 457
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 2008, DEP HLTH HUMAN SERVI, P1
[2]  
Autran B, 1999, ANTIVIR THER, V4, P3
[3]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[4]   Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection [J].
Domingo, P ;
Torres, OH ;
Ris, J ;
Vazquez, G .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08) :605-609
[5]  
French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x
[6]   Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa [J].
Lawn, Stephen D. ;
Myer, Landon ;
Bekker, Linda-Gail ;
Wood, Robin .
AIDS, 2007, 21 (03) :335-341
[7]   Immune restoration and CD4+T-cell function with antiretroviral therapies [J].
Lederman, MM .
AIDS, 2001, 15 :S11-S15
[8]   The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome [J].
Manabe, Yukari C. ;
Kesavan, Anup K. ;
Lopez-Molina, Javier ;
Hatem, Christine L. ;
Brooks, Megan ;
Fujiwara, Ricardo ;
Flochstein, Karl ;
Pitt, M. Louise M. ;
Tufariello, Joann ;
Chan, John ;
McMurray, David N. ;
Bishai, William R. ;
Dannenberg, Arthur M., Jr. ;
Mendez, Susana .
TUBERCULOSIS, 2008, 88 (03) :187-196
[9]   Immune reconstitution inflammatory syndrome - Risk factors and treatment implications [J].
Manabe, Yukari C. ;
Campbell, James D. ;
Sydnor, Emily ;
Moore, Richard D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (04) :456-462
[10]   High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors [J].
Martínez, E ;
Gatell, J ;
Morán, Y ;
Aznar, E ;
Buira, E ;
Guelar, A ;
Mallolas, J ;
Soriano, E .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1510-1513